Association between initial symptoms and subsequent hospitalization in outpatients with COVID-19: A cohort study.
暂无分享,去创建一个
S. Mubareka | N. Daneman | A. Simor | N. Andany | J. Estrada-Codecido | A. Zhabokritsky | S. MacPhee | A. Santoro | Adrienne Kit Chan | Philip Wai-Hei Lam | Jerome Allen Leis
[1] S. Mubareka,et al. Diagnostic accuracy of subjective dyspnoea in detecting hypoxaemia among outpatients with COVID-19: a retrospective cohort study , 2021, BMJ Open.
[2] M. Killerby,et al. Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020 , 2021, Emerging infectious diseases.
[3] C. Hoong,et al. Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms , 2021, International Journal of Infectious Diseases.
[4] C. Qin,et al. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19 , 2020, Cell Research.
[5] D. Raoult,et al. Asymptomatic hypoxia in COVID-19 is associated with poor outcome , 2020, International Journal of Infectious Diseases.
[6] J. Obasanya,et al. Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria , 2020, International Journal of Infectious Diseases.
[7] S. Parisi,et al. Viral arthritis and COVID-19 , 2020, The Lancet Rheumatology.
[8] F. Bishehsari,et al. S1358 Gastrointestinal Symptoms Predict the Outcomes of COVID-19 Infection , 2020 .
[9] C. Fung,et al. Predicting severe outcomes in Covid-19 related illness using only patient demographics, comorbidities and symptoms , 2020, The American Journal of Emergency Medicine.
[10] Y. Manabe,et al. The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study , 2020, medRxiv.
[11] M. Kattan,et al. Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19 , 2020, PloS one.
[12] Manish M Patel,et al. Characteristics of Adult Outpatients and Inpatients with COVID-19 — 11 Academic Medical Centers, United States, March–May 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[13] Chaoqun Han,et al. Diarrhea and altered inflammatory cytokine pattern in severe coronavirus disease 2019: Impact on disease course and in‐hospital mortality , 2020, Journal of gastroenterology and hepatology.
[14] David A. Drew,et al. Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app , 2020, Science Advances.
[15] Jin-Min Yuan,et al. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis , 2020, International Journal of Public Health.
[16] Robert Brown,et al. Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19 , 2020, The American Journal of Emergency Medicine.
[17] Leora I. Horwitz,et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study , 2020, BMJ.
[18] Fei-Ran Guo. Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis , 2020, Tobacco induced diseases.
[19] M. Shi,et al. Enteric involvement in hospitalised patients with COVID-19 outside Wuhan , 2020, The Lancet Gastroenterology & Hepatology.
[20] Anna Stachel,et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] S. Mubareka,et al. A virtual care program for outpatients diagnosed with COVID-19: a feasibility study. , 2020, CMAJ open.
[22] Centers for Disease Control and Prevention CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[23] C. Vardavas,et al. COVID-19 and smoking: A systematic review of the evidence , 2020, Tobacco induced diseases.
[24] G. Lippi,et al. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) , 2020, European Journal of Internal Medicine.
[25] G. Remuzzi,et al. COVID-19 and Italy: what next? , 2020, The Lancet.
[26] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[27] De-Min Han,et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality , 2020, Frontiers in Public Health.
[28] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[29] G. Foster,et al. Shorter treatments for hepatitis C: another step forward? , 2015, The Lancet.